Kenneth Moch I.'s Insider Trades & SAST Disclosures
Kenneth Moch I.'s most recent trade in Gamida Cell Ltd was a trade of 200,000 Ordinary Shares done . Disclosure was reported to the exchange on Jan. 31, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Kenneth Moch I..To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Gamida Cell Ltd | Kenneth Moch I. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 200,000 | 232,300 | - | 0 | Ordinary Shares | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 71,736 | 71,736 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2023 | 47,824 | 75,893 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 13 Jun 2023 | 115 | 75,778 (0%) | 0% | 0.3 | 40 | Common Stock |
| Gamida Cell Ltd | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 56,600 | 56,600 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Feb 2023 | 28,300 | 32,300 | - | 0 | Ordinary Shares | |
| Gamida Cell Ltd | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 9,500 | 9,500 | - | - | Share Option (Right to Buy) | |
| Gamida Cell Ltd | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Nov 2022 | 2,000 | 4,000 | - | 0 | Ordinary Shares | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 34,663 | 34,663 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2022 | 23,109 | 28,109 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Sale of securities on an exchange or to another person at price $ 1.00 per share. | 14 Jun 2022 | 40 | 28,069 (0%) | 0% | 1 | 40 | Common Stock |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 7,500 | 7,500 | - | - | Stock Option (right to buy) | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Aug 2021 | 5,000 | 5,000 (0%) | 0% | 0 | Common Stock | |
| Zynerba Pharmaceuticals Inc | Kenneth I. Moch | None | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 10 Jun 2020 | 15,000 | 15,000 | - | - | Stock Option (right to buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges